Protein biomarker discovery and implementation – from broad screening to validated signatures and custom panel development
Would you like to hear the latest on how protein biomarkers are making an impact in areas from wellness profiling to large scale epidemiological initiatives and the identification of a protein signature for ovarian cancer?
“Protein biomarker discovery and implementation – from broad screening to validated signatures and custom panel development“ is being jointly arranged by the Clinical Biomarker facility at SciLifeLab Uppsala and Olink Proteomics. The event will feature presentations from three leading Swedish researchers, after which a lunch will be provided. Attendance is free, but registration is required using the link provided at the end of this email.
Date: Tuesday September 17, 2019
Venue: SciLifeLab/Navet, BMC E10:1307-1309, Uppsala
- Linn Fagerberg, SciLifeLab, KTH: “Longitudinal wellness profiling”
- Karl Michaëlsson, Uppsala University: ”On SIMPLER use of Olink’s proteomics – examples from a national research infrastructure”
- Stefan Enroth, Uppsala University: “A custom panel with absolute quantification in detection of ovarian cancer”